4|0|Public
50|$|The PMA analog {{is twice}} the potency as the <b>tenamfetamine</b> analog.|$|E
50|$|When MDA {{was under}} {{development}} as a potential pharmaceutical drug, it was given the international nonproprietary name (INN) of <b>tenamfetamine.</b>|$|E
5000|$|Blauer {{checked into}} the New York Psychiatric Institute in late 1952, seeking help for {{depression}} following a divorce. While at the facility, he {{was used as a}} test subject in experiments conducted by the Army Chemical Corps. The Army had a classified agreement with the psychiatric institute that allowed them to study possible chemical warfare compounds by administering the substances to patients. 450 mg of MDA (<b>tenamfetamine),</b> an analogue of the recreational drug MDMA, was administered intravenously as part of the Army's study which killed Blauer on January 8, 1953.|$|E
40|$|Es wurde ein gaschromatographisch-massenspektrometrisches (GC/MS) -Verfahren zum Screening und Nachweis von Morphin (4, 5 alpha-Epoxy- 17 -methyl- 7 -morphinen- 3, 6 alpha-diol), Codein (4, 5 alpha-Epoxy- 3 -methoxy- 17 -methyl- 7 -morphinen- 6 alpha-ol), Heroin (4, 5 alpha-Epoxy- 17 -methyl- 7 -morphinen- 3, 6 alpha-diyldiacetat), Kokain ((-) -Methyl-[3 beta-benzoyloxy- 2 beta(1 alphaH, 5 alphaH) -tropancarboxylat]), Benzoylecgonin (Tropin- 2 -carbonsäure-benzoylester, Methylecgonin (Tropin- 3 -carbonsäure-methylester), Cocethylen ((-) -Ethyl-[3 beta-benzoyloxy- 2 beta(1 alphaH, 5 alphaH) -tropancarboxylat]), THC (Delta- 9 -tetrahydrocannabinol), THC-Carbonsäure (11 -Nor- 9 -carboxy-delta- 9 -tetrahydrocannabinol),, 11 -OH-THC (11 -hydroxy-delta- 9 -tetrahydrocannabinol), Amphetamin ((±) -alpha-Methylphenethylamin), Methamphetamin (N,alpha-Dimethylphenethylamin), MDA (Methylendioxyamphetamin; Tenamfetamin, alpha-Methyl- 3, 4 -methylendioxy-phenethylamin), MDMA (Methylendioxymethamphetamin; N,alpha-Dimethyl- 3, 4 -methylendioxy-phenethylamin) und MBDB (N-Methylbenzodioxazolylbutanamin) in kleinen Blutproben und Blutspuren unter Verwendung von Festphasen-SPE-Säulen und einem Pipettierroboter (Gilson Aspec XL) beschrieben. Die Nachweisgrenzen liegen zwischen 1, 62 und 4, 10 ng / 50 µl Spot (Amphetaminderivate), 0, 15 und 0, 82 ng / 50 µl Spot (Cannabinoide), 1, 67  4, 70 ng / 50 µl Spot (Kokain und dessen Derivate) sowie 4, 53 und 4, 91 ng / 50 µl Spot (Opiate) und die Korrelationsfaktoren zwischen 0, 9957 und 0, 9999. Weiterhin wurde die Nachweisbarkeit auf verschiedenen Spurenträgern (Holz, Stoff (Textil), Metall, Fliesen und Glas) untersucht. Dabei ergab sich, dass ein qualitativer Nachweis noch nach {{mindestens}} 64 Tagen möglich war, die quantitative Bestimmung jedoch auf Schwierigkeiten stieß. Ursachen hierfür sind beispielsweise Chargenunterschiede der Säulenmaterialien und andere Effekte, die beim Arbeiten im spurenanalytischen Bereich in der Nähe der Nachweis- und unteren Bestimmungsgrenze von großem Einfluss sind. Mit Hilfe der im Rahmen dieser Arbeit entwickelten Methode konnten 2 spektakuläre Kriminalfälle aufgeklärt werden. A GC/MS-method {{is developed}} for the screening and detection of morphine (4, 5 a-epoxy- 17 -methyl- 7 -morphinen- 3, 6 a-diol), codeine (4, 5 a-epoxy- 3 -methoxy- 17 -methyl- 7 -morphinen- 6 a-ol), heroin (4, 5 a-epoxy- 17 -methyl- 7 -morphinen- 3, 6 a-diyldiacetate), cocaine ((-) -methyl-[3 beta-benzoyloxy- 2 ß(1 alphaH, 5 alphaH) -tropancarboxylate]), benzoylecgonine (tropin- 2 -carboxylic acid-benzoylester, methylecgonin (tropin- 3 -carboxylic acid-methylester), cocethylene ((-) -ethyl-[3 beta-benzoyloxy- 2 beta(1 alphaH, 5 alphaH) -tropancarboxylate]), THC (delta- 9 -tetrahydrocannabinol), THC-carbonic acid (11 -Nor- 9 -carboxy-delta- 9 -tetrahydrocannabinol), 11 -OH-THC (11 -hydroxy-delta- 9 -tetrahydrocannabinol), amphetamine ((±) -alpha-methylphenethylamine), methamphetamin (N,alpha-dimethylphenethylamine), MDA (methylendioxyamphetamine; <b>tenamfetamine,</b> alpha-methyl- 3, 4 -methylendioxy-phenethylamine), MDMA (methylenedioxymethamphetamine; N,alpha-dimethyl- 3, 4 -methylendioxy-phenethylamine) und MBDB (N-methylbenzodioxazolylbutanamine) in small blood samples and bloodstains using solid phase SPE columns and a pipetting robot (Gilson Aspec XL). The detection limits are {{in the order of}} 1. 62  4. 10 ng / 50 µl spot (amphetamines), 0. 15  0. 82 ng / 50 µl spot (cannabinoids), 1. 67  4. 70 ng / 50 µl spot (cocaine and derivatives) and 4. 53  4. 91 ng / 50 µl spot (opiates) and the correlation factors are between 0. 9957 and 0. 9999. The method has proven useful in forensic cases with only small sample volumes or bloodstains. Furthermore the detectability was tested using different trace-carriers (wood, textiles, metal, floor-tiles und glass). These investigations resulted in qualitative detectabilities within at least 64 days. The quantitative determination however raised difficulties, mainly caused by different brands of columns and other effects which are of important influence when working in the analytical range near the detection- and lower determination limit, respectively. By means of the methods developed within the scope of this study, two spectacular crime cases could be cleared up...|$|E

